| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.23B | 1.15B | 2.84B | 1.64B | 3.51B | 3.52B |
| Gross Profit | 12.52M | 13.99M | 92.37M | -344.72M | 74.10M | 40.93M |
| EBITDA | -124.54M | -626.25M | -1.73B | -1.39B | -632.84M | -370.04M |
| Net Income | -1.24B | -1.26B | -2.68B | -2.83B | -1.78B | -1.57B |
Balance Sheet | ||||||
| Total Assets | 4.72B | 4.83B | 5.64B | 11.11B | 15.74B | 16.99B |
| Cash, Cash Equivalents and Short-Term Investments | 49.47M | 36.81M | 66.15M | 68.39M | 164.94M | 229.62M |
| Total Debt | 5.21B | 5.02B | 5.08B | 6.82B | 11.11B | 11.12B |
| Total Liabilities | 12.69B | 12.42B | 11.95B | 14.77B | 16.58B | 15.88B |
| Stockholders Equity | -8.09B | -7.62B | -6.35B | -3.70B | -850.62M | 1.10B |
Cash Flow | ||||||
| Free Cash Flow | -12.32M | 90.48M | 686.56M | -53.24M | 14.40M | -641.08M |
| Operating Cash Flow | -9.97M | 93.57M | 689.21M | -42.48M | 453.89M | -329.37M |
| Investing Cash Flow | 7.89M | -2.19M | 1.19B | 92.14M | -357.34M | 258.15M |
| Financing Cash Flow | -6.21M | -119.89M | -1.87B | -115.99M | -158.42M | 22.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | HK$86.40M | 3.72 | 3.61% | ― | -12.19% | 108.93% | |
55 Neutral | HK$138.12M | -1.37 | -2.05% | ― | -13.57% | 34.43% | |
54 Neutral | HK$116.30M | 15.57 | 0.07% | ― | 5.65% | ― | |
50 Neutral | HK$255.00M | -1.48 | -15.93% | ― | -25.21% | 12.04% | |
48 Neutral | HK$58.47M | -0.06 | ― | ― | -15.10% | 31.07% | |
39 Underperform | HK$59.67M | 0.88 | 61.00% | ― | -41.93% | 76.10% |
China Huajun Group Limited has provided a quarterly update on its action plan to address the auditor’s disclaimer of opinion on its ability to continue as a going concern, focusing on offshore debt restructuring and equity financing measures. The company’s offshore debt restructuring via a scheme of arrangement became effective on 26 June 2025, with claims from scheme creditors currently under adjudication and an obligation to issue 24.6 million new shares to those creditors by June 2026. Separately, China Huajun has agreed to issue 12 million new shares at HK$1 each under a general mandate, expected to raise net proceeds of HK$11.9 million for general working capital and debt repayment, with the subscription long stop date extended to 31 May 2026. These steps underscore the board’s efforts to shore up liquidity, reduce leverage and resolve the going-concern qualification, developments that are closely watched by shareholders and potential investors given their implications for balance-sheet strength and future access to capital.
The most recent analyst rating on (HK:0377) stock is a Hold with a HK$0.94 price target. To see the full list of analyst forecasts on China Huajun Group Limited stock, see the HK:0377 Stock Forecast page.
China Huajun Group Limited has announced a further extension of the long stop date for the completion of a subscription of new shares under its general mandate, reflecting delays in satisfying the conditions precedent under the subscription agreement. The parties have agreed to move the deadline from 31 December 2025 to 31 May 2026, while keeping all other terms and conditions of the subscription agreement and related supplemental agreement unchanged, indicating that the prospective equity fundraising remains on track but subject to additional time for procedural or regulatory fulfillment.
The most recent analyst rating on (HK:0377) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on China Huajun Group Limited stock, see the HK:0377 Stock Forecast page.